Viewing StudyNCT00494234



Ignite Creation Date: 2024-05-05 @ 5:36 PM
Last Modification Date: 2024-10-26 @ 9:34 AM
Study NCT ID: NCT00494234
Status: COMPLETED
Last Update Posted: 2024-01-19
First Post: 2007-06-27

Brief Title: Study to Assess The Efficacy and Safety of a PARP Inhibitor For The Treatment of BRCA-positive Advanced Breast Cancer
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Breast Neoplasms
Keywords:
Name View
BRCA2 protein View
Advanced breast cancer View
PolyADP ribose polymerases View
AZD2281KU-0059436 olaparib View
BRCA1 protein View